Elanco Animal Health (ELAN) Tax Provisions (2017 - 2026)
Elanco Animal Health (ELAN) reported Tax Provisions of $30.0 million for Q1 2026, up 528.57% on a YoY basis from $4.8 million in Q1 2025, and up 76.47% sequentially from $17.0 million in Q4 2025.
Elanco Animal Health (ELAN) Tax Provisions (2017 - 2026) Analysis & Trends
Elanco Animal Health (ELAN) has 10 years of Tax Provisions data on file, last reported at $30.0 million in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions rose 528.57% year-over-year to $30.0 million; the trailing twelve-month figure through Mar 2026 stood at $45.0 million (down 72.39% YoY), and the FY2025 full-year result was $8.0 million, down 94.67% from the prior year.
- Tax Provisions climbed to $30.0 million in Q1 2026, from $17.0 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $195.0 million in Q3 2024 to a low of -$43.0 million in Q4 2024.
- A 5-year average of $13.5 million and a median of $14.0 million in 2023 frame the typical range for Tax Provisions.
- Peak annual rise in Tax Provisions reached 19600.0% in 2024, while the deepest fall reached 500.0% in 2024.
- Tracing ELAN's Tax Provisions over 5 years: stood at -$35.0 million in 2022, then jumped by 140.0% to $14.0 million in 2023, then slumped by 407.14% to -$43.0 million in 2024, then surged by 139.53% to $17.0 million in 2025, then soared by 76.47% to $30.0 million in 2026.
- Business Quant data shows ELAN's Tax Provisions at $30.0 million in Q1 2026, $17.0 million in Q4 2025, and -$16.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 67.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 157.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 676.90 Mn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 43.40 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -423.70 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 48.90 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 30.00 Mn |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | 18.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.00 Mn |
| Dec 31, 2025 | 17.00 Mn |
| Sep 30, 2025 | -16.00 Mn |
| Jun 30, 2025 | 14.00 Mn |
| Mar 31, 2025 | -7.00 Mn |
| Dec 31, 2024 | -43.00 Mn |
| Sep 30, 2024 | 195.00 Mn |
| Jun 30, 2024 | 18.00 Mn |
| Mar 31, 2024 | -20.00 Mn |
| Dec 31, 2023 | 14.00 Mn |
| Sep 30, 2023 | -1.00 Mn |
| Jun 30, 2023 | 18.00 Mn |
| Mar 31, 2023 | 5.00 Mn |
| Dec 31, 2022 | -35.00 Mn |
| Sep 30, 2022 | 21.00 Mn |
| Jun 30, 2022 | -4.00 Mn |
| Mar 31, 2022 | 24.00 Mn |
| Dec 31, 2021 | -15.00 Mn |
| Sep 30, 2021 | -22.00 Mn |
| Jun 30, 2021 | -37.00 Mn |